[II. Future perspectives of intraperitoneal chemotherapy for ovarian cancer]

Gan To Kagaku Ryoho. 2014 Feb;41(2):184-7.
[Article in Japanese]
No abstract available

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Female
  • Humans
  • Infusions, Parenteral
  • Ovarian Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents